Ignite Creation Date:
2024-05-06 @ 5:16 PM
Last Modification Date:
2024-10-26 @ 2:25 PM
Study NCT ID:
NCT05253807
Status:
COMPLETED
Last Update Posted:
2023-11-21
First Post:
2022-02-14
Brief Title:
Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer With an FGFR Alteration
Sponsor:
Organization:
Incyte Corporation